Jean-Luc M. Lemercier, CVP, EMEACLA and JAPAC at Edwards Lifesciences Corp (EW), sold 6,640 shares at $83.10 ($552K) on 2023-04-06, disclosed to the SEC on 2023-04-06.
Scheduled sale ($552k) by CVP, EMEACLA and JAPAC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EW | SELL | 2024-03-11 | $1.3M | — | Filing → |
| EW | SELL | 2023-05-09 | $1.2M | — | Filing → |
| EW | SELL | 2023-03-08 | $1.0M | — | Filing → |